off label uses for glp 1 Insights from Specialty Physicians on GLP-1RA Medications Off-Label Use Off-label GLP-1 use highlights the

60 Patients treated with exenatide once weekly experienced significantly higher rates of injection-site related adverse events (22.0%) compared to patients treated with exenatide twice daily (12.7%)

The outcome of interest was pancreatic cancer

*Correspondence: Smita Kumar, [email protected] This article was submitted to Plant Traffic and Transport, a section of the journal Frontiers in Plant Science Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

For those seeking lower-cost alternatives, Metformin remains a first-line treatment for type 2 diabetes